Generate Biomedicines, Inc.
NASDAQGenerate Biomedicines has put together one of the cleaner biotech rallies of the past month, gaining 29% since early June, yet the borrow market tells a more cautious story beneath the surface. The most telling shift this week is in the lending pool. Availability has tightened sharply — from above 270% a week ago to roughly 204% now, a 32% compression in a single week. That is…
GENB short interest surges 58% in one week to 3.16M shares, now at 43.1 ORTEX short score following positive analyst revisions.
Snapshot as of 15 Aug 2026
Generate Biomedicines has put together one of the cleaner biotech rallies of the past month, gaining 29% since early June, yet the borrow market tells a more cautious story beneath the surface. The most telling shift…
Generate Biomedicines has rarely been noisier. The stock is up 17% on the week, short sellers are piling in at the fastest pace since listing, and Nvidia just revealed a fresh stake — all at the same time. The short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GENB — free to start on ORTEX.
Sign up for free →Open GENB on ORTEX